Our mission is to improve every patient's lung cancer care by empowering physicians with swift, comprehensive, and actionable insights.
Working alongside clinicians and scientists, we boldly question the status quo and employ innovative approaches to swiftly deliver actionable results.
Our blood-based tests leverage genomics and proteomics to uncover individualized insights about the tumor biology and the patient's immune response.
As a devoted partner, we strive to transform lung cancer care standards. By equipping clinicians with the right information at the right time, we empower personalized care for each patient.
We provide our biopharma partners with end-to-end diagnostic solutions from initial biomarker discovery projects to companion diagnostic partnering, including commercialization and reimbursement.